OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/23/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization103,483 mln
Float1,087 mln
Earnings Date04/23/2026
EPS
4.51
Solid
P / E
19.57
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.45
Borderline
Relative Strength
75
/ 100
Strongly outperforming
Debt / Equity
0.28
Very low leverage
Business Description
Sanofi is a global healthcare company based in Paris, France, focused on discovering, developing, and bringing to market treatments across a wide range of serious medical conditions, including cancer, rare diseases, neurological disorders, and inflammatory diseases. The company also produces a broad portfolio of vaccines protecting against illnesses such as polio, hepatitis, rabies, and respiratory infections. To strengthen its research capabilities, Sanofi has built an extensive network of partnerships with biotechnology and artificial intelligence companies, working together to advance new therapies in areas such as gene editing, protein degradation, and immune disease treatment. Founded in 1994 and formerly known as Sanofi-Aventis, the company operates on a global scale with a strong commitment to scientific innovation.